Direct BR Pharm Sourcing
We source HP VITARAN, HP VITARAN I, and HP VITARAN S through Korean B2B channels tied to BR Pharm in Wonju. Factory-sealed cartons, original labelling, and mixed-SKU quotes without a reseller markup layer.
HP VITARAN, HP VITARAN I, and HP VITARAN S are Korean polynucleotide (PN) skin boosters from BR Pharm — three clinic SKUs at PN 20 mg/mL under one MFDS licence. Clinics ordering Vitaran wholesale restock this toolkit on mixed Korean B2B quotes for periocular and facial PN chairs.
BR Pharm’s HP VITARAN family occupies a clear lane in the Korean aesthetics market: a polynucleotide sodium (PN) intradermal skin booster — not an HA filler and not a toxin vial. For clinics that standardise on PN skin quality work, a Vitaran bulk order covers three named cartons under one MFDS licence, with CE MDR Class III family positioning and ambient 1–30°C logistics that simplify restock planning.
Yaksu Medi operates from South Korea within documented BR Pharm supply channels. Every unit we export ships factory-sealed — no secondary reseller layer, no inflated landed cost. Clinics across Europe, the Middle East, and the Americas use us to keep a reliable Vitaran wholesale cadence for periocular and facial PN chairs.
We source HP VITARAN, HP VITARAN I, and HP VITARAN S through Korean B2B channels tied to BR Pharm in Wonju. Factory-sealed cartons, original labelling, and mixed-SKU quotes without a reseller markup layer.
HP for standard facial PN restock, I for periocular chairs, S when the protocol names that carton. All three share MFDS 제허 23-784 and PN 20 mg/mL — one licence, one mix quote.
Store and ship inside 1–30°C, protected from light, with shelf life up to 3 years. No toxin cold-chain fridge requirement — simpler packing and clearer cost control on recurring restock.
United Kingdom, Germany, France, Italy, Spain, Poland, Albania
United Arab Emirates (Dubai), Saudi Arabia, Qatar, Kuwait, Turkey
United States, Canada, Mexico, Brazil, Colombia, Argentina
Japan, Thailand, Australia
To request a B2B quote, send your HP / I / S mix and destination via WhatsApp. For clinics already stocking Vitaran, we support direct restock planning. See our Skin boosters wholesale category for related PN and HA options.
From first inquiry to clinic delivery, here is how a Vitaran wholesale order progresses through our export workflow.
Contact us via WhatsApp with your HP / I / S mix, destination country, and estimated monthly box count so we can build a precise B2B quote.
We verify Korean stock, remaining dating, and whether your requested mix can ship together under ambient light-protected packing.
A proforma invoice locks carton names, quantities, and pricing. Light-protected packing requirements for the 1–30°C window are confirmed at this stage.
Upon payment, we move factory-sealed cartons into pack-out. Single-use prefilled syringe packs stay sealed until clinic receipt.
Shipments go via FedEx International Priority, EMS, or dedicated air freight depending on volume and destination. Container routing is available for large distributor orders.
Tracking is shared on dispatch. After delivery, we support your next restock — including HP / I / S mix adjustments based on chair demand.
All three aesthetics cartons share the same PN concentration and MFDS licence. Choose by chair focus — standard facial (HP), periocular (I), or S-named protocols — not by inventing different HA grades or toxin unit strengths.
| Variant | Best for | Depth / Area | Needle | Lidocaine | Procurement note |
|---|---|---|---|---|---|
| HP VITARAN | Standard facial PN restock — the core carton in most clinic mixes | Intradermal — labelled crow’s feet; facial PN chairs in clinic use | 33G × 4 mm (typical distributor pack; confirm IFU) | None | Workhorse SKU for first Vitaran wholesale orders and ongoing restock |
| HP VITARAN I | Periocular PN chairs and comfort-focused crow’s-feet protocols | Intradermal periocular — same MFDS crow’s-feet label as HP and S | 34G × 4 mm (typical distributor pack; confirm IFU) | None | May appear as HP Cell VITARAN i in selected export markets — quote the carton name on the PO |
| HP VITARAN S | Mix-tail SKU when protocols call for the S carton beside HP / I | Intradermal — same crow’s-feet MFDS label; clinic menus may extend to texture zones | 30G × 13 mm (typical distributor pack; confirm IFU) | None | Official BR Pharm SKU under 23-784 — add to the mix when the protocol names S |
Specs: PN 20 mg/mL · MFDS 제허 23-784 · typically 1 mL × 2 PFS · intradermal
HP VITARAN is the standard BR Pharm PN skin-booster carton under MFDS 제허 23-784. Clinics stock it as the facial PN workhorse — polynucleotide sodium at 20 mg/mL in a typical dual-syringe box, ready for intradermal protocols. Most mixed Vitaran quotes start here and add I or S as chair demand grows.
Specs: PN 20 mg/mL · MFDS 제허 23-784 · typically 1 mL × 2 · periocular-oriented
HP VITARAN I is the periocular-oriented SKU on the same MFDS licence. Clinics add it when crow’s-feet and under-eye PN chairs need a dedicated Eye / i carton. Ionization-adjusted formulation positioning supports comfort-focused periocular work; name the exact carton on the purchase order so pack-out matches your chair plan.
Specs: PN 20 mg/mL · MFDS 제허 23-784 · typically 1 mL × 2 · intradermal
HP VITARAN S completes the three-SKU aesthetics toolkit on the same MFDS licence. Clinics include S when the protocol calls for that named carton alongside standard HP and periocular I. Same PN concentration and labelled crow’s-feet purpose — differentiated by carton and typical needle presentation for clinic mix planning.
Two English documents support clinic buyers evaluating Vitaran for wholesale procurement — a concise fact sheet for the HP / I / S family and the peer-reviewed comfort study for HP Vitaran I.
Clinic-facing overview of the HP VITARAN / I / S PN skin-booster family — concentration, pack format, MFDS and CE MDR positioning, storage, and SKU mix notes for wholesale buyers.
Download Fact Sheet (PDF)Peer-reviewed split-face study of ionization-adjusted HP Vitaran I versus a conventional PN comparator — lower mean injection pain with comparable efficacy scores. Useful for periocular chair planning.
Download Clinical PDFUse these three checks on every received shipment before the product reaches the treatment chair.
Confirm the outer carton reads HP VITARAN, HP VITARAN I, or HP VITARAN S as ordered. Export markets may print HP Cell VITARAN i — still match the tradename to your purchase order before accepting the shipment.
Cross-check lot number and expiry between the outer carton and each prefilled syringe label. Any mismatch is a refuse signal before the product reaches the chair.
Unopened packs belong at 1–30°C, protected from light. Reject cartons with heat damage, crushed seals, or storage claims that look like a 2–8°C toxin fridge line — this is a PN gel medical device.
Vitaran is BR Pharm’s polynucleotide sodium (PN) tissue-restoration injectable line from Wonju, Korea. The aesthetics wholesale toolkit we supply is HP VITARAN, HP VITARAN I, and HP VITARAN S — three intradermal skin-booster cartons under one MFDS licence, formulated for temporary crow’s-feet improvement in adults and used by clinics as a PN skin-quality restock beside HA filler inventory.
BR Pharm is a vertically integrated PN/PDRN manufacturer with company-managed trout aquaculture for raw-material supply, ISO 13485 quality systems, and Korea medical-device GMP. That pedigree matters for buyers who want a Korean PN line with clear carton naming, CE MDR Class III family positioning, and predictable ambient logistics.
For wholesale planning, think of Vitaran as a three-SKU restock toolkit: HP as the facial core, I for periocular chairs, and S when the protocol calls for that named carton. It is not a volumising HA filler and not a botulinum toxin vial.
The active substance is polynucleotide sodium — a DNA polymer fragment formulated as an intradermal gel at 20 mg/mL. It is not cross-linked hyaluronic acid, so BDDE residual language and toxin cold-chain rules do not apply. Clinics stock Vitaran for skin-quality and crow’s-feet PN protocols, then pair it with HA ladders or toxin lines as separate inventory.
HP Vitaran I carries an ionization-adjusted formulation story aimed at periocular comfort. In a peer-reviewed split-face study, mean injection pain was lower with the ionization-adjusted PN versus a conventional PN comparator, while efficacy scores improved on both sides without a statistical difference between arms — a useful comfort signal for periocular chair planning.
Korean confirmatory programme reporting for crow’s feet cites roughly 93% of subjects achieving at least a one-grade improvement across a four-session schedule. Follow the carton IFU for technique, contraindications, and session planning.
The MFDS labelled purpose for HP VITARAN / I / S is temporary improvement of fine wrinkles at the outer corners of the eyes (crow’s feet) in adults. Clinics also schedule facial PN chairs around that labelled core. Buyers comparing our Skin boosters wholesale lane should keep labelled crow’s-feet language accurate when PN and HA sit on the same purchase order.
Primary MFDS labelled use for the skin family. HP VITARAN I is the periocular-oriented carton most clinics add for dedicated crow’s-feet and under-eye PN chairs.
HP VITARAN is the standard facial restock carton for intradermal PN protocols. Clinics typically run multi-session schedules and keep HP as the volume core of the mix.
HP VITARAN S joins the mix when the clinic protocol names that carton. Same licence and concentration as HP and I — differentiated for mix planning rather than a separate regulatory class.
Vitaran’s buyer-facing regulatory story is straightforward: Korean MFDS licensing for the aesthetics family, CE MDR Class III family positioning from the manufacturer gallery, and ISO / GMP manufacturing controls at BR Pharm’s Wonju facility.
Ambient storage at 1–30°C (light-protected) and shelf life up to 3 years keep logistics simpler than toxin cold-chain lines — a practical advantage for recurring wholesale orders.
The frames below are before-and-after visual examples for at-rest skin-quality planning in the periorbital and midface zones. They are illustrative product visuals for a PN skin booster — not toxin frown maps and not HA volume-fold corrections.
MOQ varies by destination and HP / I / S mix. Contact us via WhatsApp with your required cartons, destination country, and approximate monthly volume — we will provide a tailored B2B pricing proposal.
Yes. Mixed orders are standard. All three share MFDS 제허 23-784, so your full mix is treated as one procurement event. Name each carton on the purchase order so pack-out matches your chair plan.
Unopened packs store at 1–30°C, protected from light, with shelf life up to 3 years from manufacture. We use light-protected packing inside that window for air freight. This is not a 2–8°C toxin fridge line — FedEx International Priority and EMS are primary carriers.
We export to the United States, Canada, United Kingdom, Germany, Poland, France, Italy, Spain, Albania, UAE, Saudi Arabia, Qatar, Kuwait, Turkey, Brazil, Colombia, Argentina, Mexico, Thailand, Japan, and Australia, among others.
Confirm the carton tradename matches HP VITARAN, HP VITARAN I, or HP VITARAN S as ordered, then verify lot number and expiry on both the outer carton and each syringe. Protect packs from light and keep them inside the 1–30°C window.
Yes. The HP VITARAN family is positioned as a CE MDR Class III medical device line and holds Korean MFDS licence 제허 23-784. Injectable HP VITARAN is not FDA-cleared; MoCRA cosmetic listings for related derma-cosmetic items are not syringe approval. We quote manufacturer-named HP / I / S cartons (not reseller-only “VITARAN II” packs).
HP VITARAN is the usual first line for facial PN restock. Add HP VITARAN I for periocular chairs, and HP VITARAN S when the protocol names that carton. All three share the same MFDS licence and PN concentration.
HP VITARAN J is a separate joint line under MFDS 제허 22-99 for intra-articular use. It is not part of the aesthetics hero mix on this page — ask if you need a joint quote separately.
The Korean MFDS labelled purpose for HP VITARAN / I / S is temporary improvement of fine wrinkles at the outer corners of the eyes (crow’s feet) in adults. Clinics also use the line across facial PN protocols as a polynucleotide skin booster — not as an HA filler and not as a toxin.
Korean confirmatory programme reporting for crow’s feet cites about 93% of subjects achieving ≥1-grade improvement across four sessions. A peer-reviewed split-face study of HP Vitaran I also reported lower mean injection pain versus a conventional PN comparator with comparable efficacy scores.
No. The injectable is polynucleotide sodium (PN) in a medical-device gel. BR Pharm also manufactures PDRN for pharmaceuticals and derma-cosmetics — that is a separate product lane from the injectable skin-booster cartons.